Who investigates Extra Super P Force is effects on blood clotting? | Forum

The investigation into the effects of Extra Super P Force on blood clotting would typically fall under the purview of regulatory agencies and health authorities in different countries. In most cases, the responsibility would likely be with agencies such as the FDA (Food and Drug Administration) in the United States or the EMA (European Medicines Agency) in Europe. These agencies evaluate the safety and efficacy of medications, including their potential effects on blood clotting, through clinical trials, pharmacovigilance, and post-marketing surveillance. Healthcare providers and researchers may also conduct studies to further understand any potential risks or benefits associated with medications like Extra Super P Force.